140 related articles for article (PubMed ID: 30029648)
1. Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model.
Fan Z; Xue W; Li L; Zhang C; Lu J; Zhai Y; Suo Z; Zhao J
J Transl Med; 2018 Jul; 16(1):205. PubMed ID: 30029648
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
3. Support Vector Machine for Lung Adenocarcinoma Staging Through Variant Pathways.
Di F; He C; Pu G; Zhang C
G3 (Bethesda); 2020 Jul; 10(7):2423-2434. PubMed ID: 32444360
[TBL] [Abstract][Full Text] [Related]
4. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
[TBL] [Abstract][Full Text] [Related]
5. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
Zhou LN; Li SC; Li XY; Ge H; Li HM
Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma.
Xiao J; Liu A; Lu X; Chen X; Li W; He S; He B; Chen Q
Sci Rep; 2017 May; 7(1):2027. PubMed ID: 28515486
[TBL] [Abstract][Full Text] [Related]
7. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma.
Li S; Sun X; Miao S; Lu T; Wang Y; Liu J; Jiao W
Thorac Cancer; 2018 Aug; 9(8):924-930. PubMed ID: 29932500
[TBL] [Abstract][Full Text] [Related]
8. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
Tran N; Abhyankar V; Nguyen K; Weidanz J; Gao J
BMC Bioinformatics; 2018 Dec; 19(Suppl 20):504. PubMed ID: 30577741
[TBL] [Abstract][Full Text] [Related]
10. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
Yerukala Sathipati S; Ho SY
Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs.
Wang P; Lu S; Mao H; Bai Y; Ma T; Cheng Z; Zhang H; Jin Q; Zhao J; Mao H
Lung Cancer; 2015 May; 88(2):147-53. PubMed ID: 25758555
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study.
Kim JE; Eom JS; Kim WY; Jo EJ; Mok J; Lee K; Kim KU; Park HK; Lee MK; Kim MH
Thorac Cancer; 2018 Aug; 9(8):911-915. PubMed ID: 29806739
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide isoform-level analysis reveals tumor-specific isoforms for lung adenocarcinoma diagnosis and prognosis.
Zhuhong H; Zhenyu B; Xiangyuan C; Tingzhen X; Libin S
Cancer Genet; 2019 Jan; 230():58-65. PubMed ID: 30470588
[TBL] [Abstract][Full Text] [Related]
14. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
[No Abstract] [Full Text] [Related]
15. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
[TBL] [Abstract][Full Text] [Related]
16. A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
Wang Y; Han R; Chen Z; Fu M; Kang J; Li K; Li L; Chen H; He Y
Oncol Rep; 2016 Apr; 35(4):2257-69. PubMed ID: 26781266
[TBL] [Abstract][Full Text] [Related]
17. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
[TBL] [Abstract][Full Text] [Related]
19. GSNFS: Gene subnetwork biomarker identification of lung cancer expression data.
Doungpan N; Engchuan W; Chan JH; Meechai A
BMC Med Genomics; 2016 Dec; 9(Suppl 3):70. PubMed ID: 28117655
[TBL] [Abstract][Full Text] [Related]
20. Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors.
Wu Y; Lin L; Liu X
Dis Markers; 2020; 2020():7291586. PubMed ID: 32587640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]